3SBio Market Cap

3SBio has a market cap or net worth of 54.80 billion as of February 27, 2026. Its market cap has increased by 262.41% in one year.

Market Cap

54.80B

Enterprise Value

52.64B

Revenue

9.94B

Ranking

n/a

PE Ratio

20.88

Stock Price

21.94

Market Cap Chart

Since June 11, 2015, 3SBio's market cap has increased from 22.67B to 54.80B, an increase of 141.74%. That is a compound annual growth rate of 8.58%.

Market Cap History

Date	Market Cap	% Change
Feb 27, 2026	54.80B	-9.26%
Dec 31, 2025	60.39B	321.75%
Dec 31, 2024	14.32B	-20.61%
Dec 29, 2023	18.04B	-10.89%
Dec 30, 2022	20.24B	23.46%
Dec 31, 2021	16.40B	-8.83%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
RemeGen	57.46B
Shanghai Henlius Biotech	37.85B
Shanghai Junshi Biosciences	35.82B
Sichuan Kelun-Biotech Biopharmaceutical	93.27B
Biocytogen Pharmaceuticals (Beijing)	32.93B
Akeso	97.09B
Duality Biotherapeutics	30.29B
Sino Biopharmaceutical	114.23B

Market Cap Rankings